TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BiolacUm AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 75 | 67 | 61 |
Financial expenses | 503 | 0 | 0 |
Earnings before taxes | 419 | 40 | 32 |
EBITDA | 52 | 43 | 36 |
Total assets | 679 | 382 | 434 |
Current assets | 48 | 93 | 81 |
Current liabilities | 2 | 2 | 1 |
Equity capital | 659 | 361 | 415 |
- share capital | 9 | 10 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 97.1% | 94.5% | 95.6% |
Turnover per employee | 75 | 67 | 61 |
Profit as a percentage of turnover | 558.7% | 59.7% | 52.5% |
Return on assets (ROA) | 135.8% | 10.5% | 7.4% |
Current ratio | 2400% | 4650.0% | 8100% |
Return on equity (ROE) | 63.6% | 11.1% | 7.7% |
Change turnover | 13 | 7 | -44 |
Change turnover % | 22% | 12% | -42% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.